Klin Farmakol Farm. 2024;38(1):22-25 | DOI: 10.36290/far.2024.004

Hypertensive disease in the context of adherence and nonadherence to treatment

Iveta Ondriová, Terézia Fertaľová, Lívia Hadašová
Katedra ošetrovateľstva FZOPU v Prešove

Arterial hypertension is the most frequently occurring cardiovascular disease, it represents a serious risk factor for other cardiovascular diseases. The treatment of any disease cannot be done without the adherence of the patient himself. Through adherence, the patient demonstrates the ability to adapt and comply with individual regulations and requirements from the doctor, which increases the probability of achieving the set treatment goals and prevents possible complications.

Keywords: hypertensive disease, treatment, adherence, nonadherence.

Accepted: March 26, 2024; Published: April 8, 2024  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Ondriová I, Fertaľová T, Hadašová L. Hypertensive disease in the context of adherence and nonadherence to treatment. Klin Farmakol Farm. 2024;38(1):22-25. doi: 10.36290/far.2024.004.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Novotná Z, Hudáková A, Šimová Z, et al. Nursing in internal medicine II. 1st ed. Bački Petrovac: Srpsko razvojno udruženje; 2017:191 s.
    2. Bulava A. Kardiologie pro nelékařské zdravotnické obory. 1. vyd. Praha: Grada Publishing; 2017:345 s.
    3. Miklošovičová E, Kristová J. Komplexná ošetrovateľská starostlivosť o pacienta s hypertenziou. Ošetrovateľský obzor [online]. 2005;2:85-89. [cited 2023 Mar 11]. Available from: https://www.osetrovatelsky.herba.sk/index.php/rok-2005/60-osetrovatelsky-obzor-3-2005/207-osetrovatelsky-obzor-3-2005.
    4. Gašpar Ľ, et al. Artériová hypertenzia - rizikový faktor kardiovaskulárnych komplikácií. Vaskulárna medicína [online]. 2013;5(1):7-10. [cited 2022 Oct 15]. Available from: https://www.solen.sk/storage/file/article/ccad0d90b4299984a5da5961d4d50345.pdf.
    5. Souček M, Svačina P, et al. Vnitřní lékařství v kostce. 1. vyd. Praha: Grada Publishing; 2019:469 s.
    6. Sovová E, Sedlářová J, et al. Kardiologie pro obor ošetřovatelství. 2. vyd. Praha: Grada Publishing; 2014:264 s.
    7. Sudharsanan N, Ali MK, Mconnell M. Hypertension knowledge and treatment initiation, adherence, and discontinuation among adults in Chennai, India: a cross-sectional study. BMJ Open [online]. 2021;11(1). [cited 2023 Mar 11]. Available from: http://dx.doi.org/10.1136/bmjopen-2020-040252. Go to original source... Go to PubMed...
    8. Cífková R. Adherence a léčba hypertenze. Kapitoly z kardiologie pro praktické lékaře [online]. 2018;10(2). [cited 2023 Jan 25]. Available from: https://www.tribune.cz/archiv/adherence-a-lecba-hypertenze/.
    9. Václavík J. Obtížně léčitelná hypertenze. 2. vyd. Praha: Mladá fronta; 2017:180 s.
    10. Vrablík M, Brunerová L. Efektivní komunikace lékaře s pacientem je klíčem k úspěchu. Medicína pro praxi [online]. 2021;18(2):98-103 [cited 2023 Mar 06]. Available from: https://www.medicinapropraxi.cz/pdfs/med/2021/02/03.pdf. Go to original source...
    11. Widimský J, et al. Hypertenze. 5. vyd. Praha: Maxdorf; 2019:536 s.
    12. Vrablík M. Adherence a možnosti jejího ovlivnení. Medicína pro praxi [online]. 2013;10(11-12):369-371. [cited 2022 Nov 30]. Available from: https://www.medicinapropraxi.cz/pdfs/med/2013/11/03.pdf.
    13. Williams B, Mancia G, Spiering W, et al. ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH). European Heart Journal [online]. 2018;39(33):3021-3104. [cited 2022 Nov 30]. Available from: https://doi.org/10.1093/eurheartj/ehy339. Go to original source... Go to PubMed...
    14. Hudecová K, Mydlárová V. Farmakoterapia artériovej hypertenzie vo vybraných klinických situáciách. Kardiol. 2022;5:17-21.
    15. Jochmanová L, Kimplová T, et al. Psychologie zdraví - biologické, psychosociální, digitální a spirituální aspekty. 1. vyd. Praha: Grada Publishing; 2022:552 s.
    16. Fathi A, et al. Odvrátiteľné riziká chorôb obehovej sústavy, edukácia sestrou. 1. vyd. Štrba: Infodoktor, o. z.; 2020:287 s.
    17. Vrijens B, De Geest S, Hughes DA; ABC Project Team. A new taxonomy for describing and defining adherence to medications. Br J Clin Pharmacol. 2012;73(5):691-705. doi: 10.1111/j.1365-2125.2012.04167.x. PMID: 22486599; PMCID: PMC3403197. Go to original source... Go to PubMed...
    18. Burnier M, Egan BM. Adherence in Hypertension. Circ Res. 2019;124(7):1124-1140. doi: 10.1161/CIRCRESAHA.118.313220. PMID: 30920917. Go to original source... Go to PubMed...
    19. Uchmanowicz B, Elicher ES, et al. Factors influencing adherence to treatment in older adults with hypertension. Clinical Interventions in Aging [online]. 018 Nov 28:13: 2425-2441.doi: 10.2147/CIA.S182881. eCollection 2018. [cited 2022 Nov 30]. Go to original source...
    20. Sudharsanan N, Ali MK, Mconnell M. Hypertension knowledge and treatment initiation, adherence, and discontinuation among adults in Chennai, India: a cross-sectional study. BMJ Open [online]. 2021;11(1). [cit. 2023 Mar11]. Available from: http://dx.doi.org/10.1136/bmjopen-2020-040252. Go to original source... Go to PubMed...
    21. Macgregor GA, Stowsser M. Rýchle fakty: Hypertenzia. 1. vyd. Bratislava: Dr. Josef Raabe Slovensko; 2017:96 s.
    22. Slabá Š. Adherence k léčbě z pohledu psychologa. Athero Review [online]. 2017;2:21-24 [cited 2023 Mar 11]. Available from: https://www.prolekare.cz/casopisy/athero-review/2017-1/adherence-k-lecbe-z-pohledu-psychologa-60301/download?hl=cs.
    23. Ludka O. Motivace pacienta k celoživotnímu užívání léků u arteriální hypertenze. Medicína pro praxi [online]. 2017;14:11-14. [cited 2023 Mar 09]. Available from: https://www.medicinapropraxi.cz/pdfs/med/2017/01/03.pdf. Go to original source...
    24. Shu-Mei C, I-Cheng L, Yi-Chun C, et al. Behavioral factors associated with medication nonadherence in patients with hypertension. In: International Journal of Environmental Research and Public Health [online]. 2021;18(18):9614. [cited 2023 Mar 11]. Available from: https://doi.org/10.3390/ijerph18189614. Go to original source... Go to PubMed...
    25. Nussbaumerová B. Možnosti kombinační farmakoterapie arteriální hypertenze a dyslipidemie v ovlivnění kardiovaskulárního rizika. Medicína pro praxi [online]. 2018;15:258-260. [cited 2022 Nov 30]. Available from: https://www.internimedicina.cz/pdfs/int/2019/01/07.pdf. Go to original source...

    Return to the content


    Clinical Pharmacology and Pharmacy

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.